Cyfuse Biomedical KK (TSE:4892) EV-to-Revenue : 82.13 (As of Jun. 23, 2025)

Cyfuse Biomedical KK EV-to-Revenue Chart

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial							58.32	49.98	47.16	56.30	27.55

Competitive Comparison of Cyfuse Biomedical KK's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's EV-to-Revenue falls into.

Cyfuse Biomedical KK EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cyfuse Biomedical KK's EV-to-Revenue for today is calculated as:

Cyfuse Biomedical KK's current Enterprise Value is 円5,000.49 Mil.
Cyfuse Biomedical KK's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円60.88 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK  (TSE:4892) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cyfuse Biomedical KK's PS Ratiofor today is calculated as:

Cyfuse Biomedical KK's share price for today is 円867.00.
Cyfuse Biomedical KK's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円7.70.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyfuse Biomedical KK EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK Business Description